Friday 6 November 2026 Export TWST’s income statement to Excel — free account

Twist Bioscience Corporation

Twist Bioscience Corporation’s revenue for fiscal 2025 (year ended September 2025) was $376.6 million, up 20.3% from fiscal 2024.

Revenue: +23.2%
EPS: −264.7%
Free cash flow: −7.23%
Total debt: 0.00%

Quarter to June 2026, against a year earlier

118.35 2.26 −1.87%

Follow TWST

Alert me

Market cap: $7.9B
P/E: 0.0×
Fwd P/E: −91.4×
Dividend yield: —
F-score: 4/9
Altman Z: 3.44
Beneish M: −2.30
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Twist Bioscience Corporation (TWST) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Twist Bioscience Corporation (TWST) trades at a P/B ratio of 17.1×. Over the past ten years it has ranged from 0.0× (December 2018) to 28.7× (October 2026); the current reading is higher than 97% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/TWST/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Twist Bioscience Corporation P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/TWST/metrics/pb-ratio">Twist Bioscience Corporation (TWST) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	3.6×	(35.83%)
FY2024	5.5×	217.01%
FY2023	1.7×	(27.29%)
FY2022	2.4×	(72.93%)
FY2021	8.9×	0.37%
FY2020	8.9×	105.33%
FY2019	4.3×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/B ratio	Change
Jun 2026	14.4×	123.55%
Mar 2026	6.4×	51.67%
Dec 2025	4.2×	19.37%
Sep 2025	3.6×	(22.90%)
31 more quarters	Free account

Against its own ten years

Low 0.0× High 28.7×

Ten-year median 5.0×

Current reading's percentile 97

Company	P/B ratio
CYTK Cytokinetics, Incorporated compare	n/m
IBRX ImmunityBio, Inc. compare	n/m
KRYS Krystal Biotech, Inc. compare	6.2×
SYRE Spyre Therapeutics, Inc. compare	9.5×
PTGX Protagonist Therapeutics, Inc. compare	10.6×
CAI Caris Life Sciences,�Inc. compare	12.7×
TGTX TG Therapeutics, Inc. compare	13.6×
TWST Twist Bioscience Corporation	17.1×
MDGL Madrigal Pharmaceuticals, Inc. compare	18.7×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Twist Bioscience Corporation (TWST) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on TWST

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on TWST

Stockrow Weekly